Activating p53 and cell senescence to regress tumours

Lung cancer patients lacking MSH2 DNA repair protein fare better with chemo

Therapeutic vaccine improves response rate and extends progression-free survival in patients with metastatic melanoma

PARP inhibitor BS-201 plus chemotherapy: new option for triple-negative breast cancer

Olaparib induces tumour response as single agent in BRCA-deficient breast cancer

Standard treatment plus trastuzumab for HER2+ gastric cancer

Sentinel node biopsy is effective, less invasive option for early-stage cervical cancer patients

Treatment based on rising CA125 blood levels does not improve survival for recurrent ovarian cancer

Targeting death receptors in chemo-resistant cancer cells

Therapeutic cancer vaccine significantly prolongs disease-free survival for follicular lymphoma

Bortezomib based therapies for myeloma

Zoledronic acid for treament of prostate cancer